Last updated on 12 Feb, 2026 | 21:12 IST
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of Medicamen Biotech as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Medicamen Biotech rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Medicamen Biotech rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Medicamen Biotech hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Medicamen Biotech hasn’t had any right issues as of {{current_date}} in last 2023-2025